Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury

Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury

Exp Neurol, 2011 · DOI: 10.1016/j.expneurol.2011.06.015 · Published: October 1, 2011

Spinal Cord InjuryPhysiologyNeurology

Simple Explanation

NG2+ cells are glial progenitor cells in the CNS that can become oligodendrocytes, which are important for remyelination after spinal cord injury. This study investigates the role of matrix metalloproteinases (MMPs), particularly MMP-9, in regulating the proliferation of NG2+ cells after spinal cord injury. The researchers found that inhibiting MMP-9 immediately after spinal cord injury increased the division of NG2+ cells, but not other types of glial cells like astrocytes or microglia. This suggests that MMP-9 normally suppresses NG2+ cell proliferation. Blocking MMP-9 also reduced the shedding of certain molecules from the surface of NG2+ cells, which is believed to promote their maturation into oligodendrocytes. This ultimately led to improved myelin repair and functional recovery after spinal cord injury.

Study Duration
22 days
Participants
Adult female Sprague-Dawley rats (200-225 g)
Evidence Level
Not specified

Key Findings

  • 1
    Acute inhibition of MMP-9/2 after spinal cord injury increases the proliferation of NG2+ progenitor cells but not astrocytes or microglia.
  • 2
    MMP-9/2 inhibition reduces the shedding of NG2 proteoglycan and the NR1 subunit of the NMDA receptor.
  • 3
    Acute MMP-9/2 blockade promotes post-mitotic maturation of oligodendrocytes, improves myelin neuropathology, and facilitates functional recovery.

Research Summary

This study demonstrates that acute MMP-9/2 inhibition after spinal cord dorsal hemisection acts as a mitogen for NG2+ cells but not GFAP+ astrocytes or Iba-1+ macrophages and/or microglia. In the damaged spinal cord, MMPs control the shedding of NG2 proteoglycan and of the NR1 subunit of the N-methyl D-aspartate receptor (NMDAr), whose decline is believed to accompany NG2+ cell maturation into OLs. Acute MMP-9/2 block permits successful post-mitotic maturation of OLs, improves neuropathology of myelin, and facilitates functional (locomotion and somatosensory, bladder) recovery associated with the lesion.

Practical Implications

Therapeutic Target

MMP-9 could be a therapeutic target for promoting NG2+ cell proliferation and subsequent remyelination after spinal cord injury.

Timing is Critical

Acute, rather than extended, MMP-9 inhibition appears to be crucial for beneficial effects on spinal cord repair.

Functional Recovery

Targeting MMP-9 may lead to improved locomotion, somatosensory function, and bladder control in individuals with spinal cord injuries.

Study Limitations

  • 1
    Contribution of MMP-2
  • 2
    Mechanism of action
  • 3
    Other MMP family members

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury